Figure 3 | Scientific Reports

Figure 3

From: Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA

Figure 3

Kaplan–Meier curves for overall survival (OS) and event-free survival (EFS). (A) Cumulative percentage of 1-year OS in MSD-PTCy group compared to MSD-control group. (B) Cumulative percentage of 1-year EFS in MSD-PTCy group compared to MSD-control group. (C) Cumulative percentage of 1-year OS in the haplo-HSCT group compared to haplo-control group. (D) Cumulative percentage of 1-year EFS in the haplo-HSCT group compared to haplo-control group.

Back to article page